This is no longer a niche question
In NASM’s 2026 State of the Personal Trainer survey (1,133 trainers), 73% said clients had already asked them about GLP-1 medications. Nearly half reported more weight-loss medication users on their active rosters. Experienced coaches hear it even more often: among pros with 10+ years, regular GLP-1 inquiries were reported by about 84%.
Industry estimates put current US use in the multi-million range (NASM’s public commentary has cited figures on the order of ~12% of adults having tried a GLP-1 and more than 15 million currently using one—treat those as directional market signals, not your clinical brief). The point for trainers is simpler: if you have not been asked yet, you will be.
The right answer is not a hot take on the drug. It is a coaching plan that protects lean mass, function, and long-term habits—while staying inside your scope of practice.
What the job actually is (and is not)
You are not prescribing, titrating, or “managing” medication. That belongs to the client’s licensed clinician. NASM’s own education push around weight-loss medications exists because so many CPTs feel underprepared—and because guessing here creates both poor outcomes and liability risk.
Your lane:
- progressive resistance training that the client can complete consistently;
- behavior coaching around protein, meal structure, NEAT, sleep, and adherence;
- session adaptations for nausea, fatigue, dizziness, or low energy during dose titration;
- progress metrics that are not only body weight;
- clear referral when red flags appear.
Out of lane: dosing advice, sourcing compounded drugs, diagnosing side effects, promising “faster fat loss than the medication.”
The non-negotiable training priority: preserve muscle
NASM’s framing for the field is blunt: shift the conversation from “what’s the right cardio?” to “how do we preserve your muscle?” Rapid energy deficit plus suppressed appetite is a classic setup for losing lean tissue if the only stimulus is walking and under-eating.
Practical programming defaults for most otherwise healthy adults cleared to train:
- 2–3 full-body or upper/lower strength sessions per week as the backbone—not endless HIIT “to burn more.”
- Progressive overload when tolerated—even small load/rep improvements beat random variety.
- Machine and supported variations when energy is low; free weights when technique is solid and symptoms are quiet.
- Shorter, completable sessions beat heroic plans clients abandon mid-titration.
Club-level reports and trainer surveys repeatedly cite muscle loss as the fear GLP-1 clients walk in with. Address it explicitly in onboarding so the scale does not become the only scoreboard.
Side effects change the day’s dose—not your standards
Nausea, GI distress, fatigue, and appetite suppression are common during titration. That is not an excuse for zero training; it is a reason to have regressions ready:
- cut volume 20–40% before cutting the entire session;
- swap axial-heavy work for more supported patterns when the client feels fragile;
- keep protein and hydration conversations behavioral (“Did you eat a protein-forward meal before training?”), not clinical;
- stop the session for dizziness, severe abdominal pain, fainting risk, or anything that looks medical—send them to their provider.
Measure what the drug does not
Weight will often move with or without you. Your retained value is:
- strength logs (same lifts, same conditions);
- body composition trends if you have a consistent protocol (and you explain error bars);
- adherence streaks and weekly session completion;
- function: stairs, carry capacity, work capacity, confidence in the gym—especially for first-time members (NASM data also shows a rise in first-time gym-goers on rosters).
Reassess every 2–4 weeks. If strength is collapsing while weight crashes, the plan is failing even if the client likes the mirror this month.
Onboarding that protects retention and liability
Structured onboarding is not bureaucracy. Industry write-ups tied to trainer practice routinely link clear intake + check-in rhythm to better retention and satisfaction. For GLP-1 clients, intake should capture:
- who manages the prescription (and that you will not alter it);
- current side effects and training tolerances;
- protein/meal pattern at a coaching level;
- goals beyond the scale (strength, energy, muscle retention, exit plan when appetite returns).
Weekly or biweekly check-ins matter more here than for a stable intermediate who just wants PRs. Quiet clients on aggressive deficits are high churn risk.
Business upside without crossing the line
Facilities and trainers who treat GLP-1 users as a long coaching relationship—not a 4-week “cut package”—are positioned where medical fitness partnerships are growing (NASM’s outlook lists medical-fitness partnerships among top 3-year growth areas). Referral relationships with physicians and RDs beat Instagram pharmacology takes.
If you want formal CE, NASM’s Understanding Weight Loss Medications course exists specifically for this gap. Credential stacking is optional; scope discipline is not.
Bottom line
In the US market in 2026, GLP-1 literacy is table stakes. Coach the training and behavior plan that protects muscle and function. Stay out of the prescription pad. Track strength and adherence, not just pounds. That is how you stay useful after the novelty of the weekly injection wears off.